Literature DB >> 22089106

Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension.

Ramón C Hermida1, Diana E Ayala, Artemio Mojón, José R Fernández.   

Abstract

BACKGROUND: Elevated sleep-time blood pressure (BP) is a better predictor of cardiovascular risk than the awake or 24 h BP means. However, discrepancies in the diagnosis of hypertension between clinic and ambulatory measurements (isolated-office and masked hypertension) are frequently defined by comparing clinic with only awake BP. We evaluated the impact of sleep-time BP in the prognostic value of isolated-office and masked hypertension.
METHODS: We studied 3,344 subjects (1,718 men/1,626 women), 52.6 ± 14.5 years of age, during a median 5.6-years follow-up. Ambulatory BP was measured for 48 h at baseline, and again annually or more frequently (quarterly) after treatment adjustments in hypertensive subjects.
RESULTS: Out-of-office (masked and sustained) hypertension was associated with higher cardiovascular risk than normotension and isolated-office hypertension (P < 0.001) only when those conditions were defined on the basis of asleep, but not on awake or 24 h BP mean. Using only awake pressure for classification, 58.2% of subjects with masked hypertension were mistakenly classified as normotensive, and 26.3% of subjects with sustained hypertension were erroneously identified as isolated-office hypertensive. Cox proportional-hazard analysis using the awake and asleep pressure means as potential predictors of cardiovascular risk and adjusted for significant confounders revealed that only asleep mean was an independent significant predictor of outcome.
CONCLUSIONS: Subjects with elevated sleep-time BP are at high cardiovascular risk, independently of either clinic or ambulatory awake measurements. Sleep-time BP determined by ambulatory monitoring should thus be used for proper identification of out-of-office hypertension, a condition associated with markedly increased cardiovascular risk.
© 2012 American Journal of Hypertension, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22089106     DOI: 10.1038/ajh.2011.208

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  15 in total

Review 1.  Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Juan J Crespo; María T Ríos; Ana Moyá; Francesco Portaluppi
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

2.  The importance of masked hypertension in adults with prehypertension.

Authors:  Brent M Egan; Sean Stevens-Fabry
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 3.  Chronotherapy improves blood pressure control and reduces vascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; Artemio Mojón; José R Fernández; Juan J Crespo; Ana Moyá; María T Ríos; Francesco Portaluppi
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

Review 4.  Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction.

Authors:  R C Hermida; D E Ayala; A Mojón; M H Smolensky; F Portaluppi; J R Fernández
Journal:  J Hum Hypertens       Date:  2014-02-06       Impact factor: 3.012

5.  Metabolic risk factors and masked hypertension in the general population: the Finn-Home study.

Authors:  M-Ra Hänninen; T J Niiranen; P J Puukka; A M Jula
Journal:  J Hum Hypertens       Date:  2014-01-02       Impact factor: 3.012

Review 6.  Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk.

Authors:  Ramón C Hermida; Diana E Ayala; María T Ríos; José R Fernández; Artemio Mojón; Michael H Smolensky
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 7.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

Review 8.  KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline.

Authors:  Holly J Kramer; Raymond R Townsend; Karen Griffin; Joseph T Flynn; Daniel E Weiner; Michael V Rocco; Michael J Choi; Matthew R Weir; Tara I Chang; Rajiv Agarwal; Srinivasan Beddhu
Journal:  Am J Kidney Dis       Date:  2019-04       Impact factor: 8.860

9.  Is nighttime blood pressure important in cardiovascular risk assessment in coronary atherosclerosis?

Authors:  W Sobiczewski; M Wirtwein; M Gruchala
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 10.  Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Francesco Portaluppi
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.